跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
coagulation factor IX
首页
药物
coagulation factor IX
coagulation factor IX
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Methods for producing bispecific antibodies
EP 2824183 B1
申请人: CHUGAI PHARMACEUTICAL CO LTD
优先权: 2005
EP
US
16 件公开
Bispecific antibody substituting for functional proteins
US 2007041978 A1
申请人: HATTORI KUNIHIRO
优先权: 2003
CN
EP
US
WO
8 件公开
METHODS AND MEANS FOR THE PREVENTION AND/OR TREATMENT OF HEMOPHILIC ARTHROPATHY IN HEMOPHILIA
EP 4326882 A1
申请人: UNIQURE BIOPHARMA B V
优先权: 2021
EP
US
WO
8 件公开
MULTI-SPECIFIC ANTIGEN-BINDING MOLECULE HAVING ALTERNATIVE FUNCTION TO FUNCTION OF BLOOD COAGULATION FACTOR VIII
EP 3318633 A1
申请人: CHUGAI PHARMACEUTICAL CO LTD
优先权: 2010
EP
US
8 件公开
ANTIBODIES RECOGNISING FACTOR IX AND X FOR USE IN PROMOTING COAGULATION
EP 3848396 A1
申请人: NOVO NORDISK AS
优先权: 2017
CN
EP
US
WO
7 件公开
COAGULATION FACTOR IX COMPOSITIONS AND METHODS OF MAKING AND USING SAME
EP 3222287 A1
申请人: AMUNIX OPERATING INC
优先权: 2009
EP
US
7 件公开
MEDICINAL COMPOSITION USABLE FOR PREVENTING AND/OR TREATING BLOOD COAGULATION FACTOR IX ABNORMALITY, COMPRISING MULTISPECIFIC ANTIGEN BINDING MOLECULE REPLACING FUNCTION OF BLOOD COAGULATION FACTOR VIII
EP 3603670 A4
申请人: PUBLIC UNIV CORPORATION NARA MEDICAL UNIV
优先权: 2017
CN
EP
US
WO
6 件公开
IMPROVED PROCOAGULANT ANTIBODIES
EP 3830135 A1
申请人: NOVO NORDISK AS
优先权: 2018
CN
EP
US
WO
6 件公开
Modified coagulation factor IX polypeptides and use thereof for treatment
EP 2423305 A1
申请人: CATALYST BIOSCIENCES INC
优先权: 2007
EP
US
6 件公开
Hyperglycosylated human coagulation factor IX
EP 2811017 A2
申请人: NOVO NORDISK HEALTHCARE AG
优先权: 2008
CN
EP
US
5 件公开
第 1 / 9 页
上一页
下一页
药物
反馈